Background Among the 1.2 million people with human immunodeficiency virus (HIV) in the
United States, 25% are coinfected with hepatitis C virus (HCV). The availability of effective …

Background Among the 1.2 million people with human immunodeficiency virus (HIV) in the
United States, 25% are coinfected with hepatitis C virus (HCV). The availability of effective …

Objectives To describe a pharmacist‐led campaign aimed at reducing the proportion of
people with HIV with ongoing chronic hepatitis C virus (HCV) infection and delineating …

Background Gay and bisexual men (GBM) are a key population affected by human
immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection. We aimed to measure …

With the advent of highly effective direct-acting antivirals (DAAs) for the treatment of hepatitis
C virus (HCV), the World Health Organization (WHO) and other local, regional and national …

Background Bolstered by the high efficacy of hepatitis C virus (HCV) treatment, the World
Health Organization has called for HCV elimination by 2030. People with HIV (PWH) have …

Objective Treatment recommendations for hepatitis C now make no distinction between
HIV/HCV-coinfected and HCV-monoinfected patients. The largest challenge remained lack …

Objectives Micro‐elimination of hepatitis C virus (HCV) in people living with HIV (PLHIV) and
co‐infected with HCV has been proposed as a key contribution to the overall goal of HCV …

Introduction. Direct-acting antiviral medications have made hepatitis C virus (HCV) cure
possible for> 95% of persons with chronic HCV infection, including those coinfected with …

Background Rising incidence of hepatitis C virus (HCV) among people with HIV (PWH) in
San Diego County (SDC) was reported. In 2018, the University of California San Diego …